Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Salom

Showing results (81-90 of 87) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 87 results.
Mediators of Inflammation|February 4, 2014
Usefulness of adalimumab in the treatment of refractory uveitis associated with juvenile idiopathic arthritisCarmen García-De-Vicuña, Manuel Díaz-Llopis, David Salom, et al.
Ophthalmology|April 25, 2012
Treatment of refractory uveitis with adalimumab: a prospective multicenter study of 131 patientsManuel Díaz-Llopis, David Salom, Carmen Garcia-de-Vicuña, et al.
Molecular Vision|April 6, 2013
Lack of association between the protein tyrosine phosphatase non-receptor type 22 R263Q and R620W functional genetic variants and endogenous non-anterior uveitisMaría Carmen Cénit, Ana Márquez, Miguel Cordero-Coma, et al.
Nature Biomedical Engineering|November 28, 2024
Safer and efficient base editing and prime editing via ribonucleoproteins delivered through optimized lipid-nanoparticle formulationsRafał Hołubowicz, Samuel W Du, Jiin Felgner, et al.
Ophthalmology|April 1, 2018
Successful Optimization of Adalimumab Therapy in Refractory Uveitis Due to Behçet's DiseaseJosé Luis Martín-Varillas, Vanesa Calvo-Río, Emma Beltrán, et al.
American Journal of Human Genetics|March 13, 2025
Bi-allelic variants in three genes encoding distinct subunits of the vesicular AP-5 complex cause hereditary macular dystrophyKarolina Kaminska, Francesca Cancellieri, Mathieu Quinodoz, et al.
Rheumatology (Oxford, England)|July 6, 2014
Anti-TNF-α therapy in patients with refractory uveitis due to Behçet's disease: a 1-year follow-up study of 124 patientsVanesa Calvo-Río, Ricardo Blanco, Emma Beltrán, et al.
Pageof 9

Showing results (81-90 of 87) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 87 results.
Mediators of Inflammation|February 4, 2014
Usefulness of adalimumab in the treatment of refractory uveitis associated with juvenile idiopathic arthritisCarmen García-De-Vicuña, Manuel Díaz-Llopis, David Salom, et al.
Ophthalmology|April 25, 2012
Treatment of refractory uveitis with adalimumab: a prospective multicenter study of 131 patientsManuel Díaz-Llopis, David Salom, Carmen Garcia-de-Vicuña, et al.
Molecular Vision|April 6, 2013
Lack of association between the protein tyrosine phosphatase non-receptor type 22 R263Q and R620W functional genetic variants and endogenous non-anterior uveitisMaría Carmen Cénit, Ana Márquez, Miguel Cordero-Coma, et al.
Nature Biomedical Engineering|November 28, 2024
Safer and efficient base editing and prime editing via ribonucleoproteins delivered through optimized lipid-nanoparticle formulationsRafał Hołubowicz, Samuel W Du, Jiin Felgner, et al.
Ophthalmology|April 1, 2018
Successful Optimization of Adalimumab Therapy in Refractory Uveitis Due to Behçet's DiseaseJosé Luis Martín-Varillas, Vanesa Calvo-Río, Emma Beltrán, et al.
American Journal of Human Genetics|March 13, 2025
Bi-allelic variants in three genes encoding distinct subunits of the vesicular AP-5 complex cause hereditary macular dystrophyKarolina Kaminska, Francesca Cancellieri, Mathieu Quinodoz, et al.
Rheumatology (Oxford, England)|July 6, 2014
Anti-TNF-α therapy in patients with refractory uveitis due to Behçet's disease: a 1-year follow-up study of 124 patientsVanesa Calvo-Río, Ricardo Blanco, Emma Beltrán, et al.
Pageof 9